A novel allogeneic off-the-shelf dendritic cell vaccine for post-remission treatment of elderly patients with acute myeloid leukemia

Author(s):
Loosdrecht, A.A. van de; Wetering, S. van; Santegoets, S.J.A.M.; Singh, S.K.; Eeltink, C.M.; Hartog, Y. den; Koppes, M.; Kaspers, J.; Ossenkoppele, G.J.; Kruisbeek, A.M.; Gruijl, T.D. de
Published
2018
Publication type
Article / Letter to editor
Dendritic cellsImmune therapyAcute myeloid leukemiaPhase I trial
Date issued
2018-10-31
Language
English
Is part of
Cancer Immunology, Immunotherapy (2018), Vol. 67, no. 10, p. 1505-1518
hdl
1887/75720
doi
10.1007/s00262-018-2198-9